Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2025 / December / Parkinsons Aggravated byNanoplastics Exposure
Neurology Omics Microbiology and Immunology Research and Innovations

Parkinson's Aggravated by Nanoplastics Exposure

Mouse study suggests environmental nanoplastics may exacerbate Parkinson's disease through metabolic dysregulation in the gut, brain, and liver

By Kathryn Wighton 12/12/2025 News 3 min read

Share

Polystyrene nanoplastics were evaluated in an A53T α-synuclein mouse model to assess gastrointestinal, metabolic, hepatic, and neurologic outcomes after chronic exposure. In this study, published in npj Parkinson’s Disease, mice were fed polystyrene nanoplastics every other day for three months. This followed intestinal administration of A53T α-synuclein to mimic Parkinson's disease pathology.

The researchers found that mice exposed to nanoplastics had fewer mucus-producing cells in part of the small intestine and more cell death in the gut lining. This happened whether or not the mice carried the A53T α-synuclein gene mutation. The gut bacteria of nano-plastic exposed mice also differed, showing a wider mix of microbes than the control mice, including more of a type of bacteria called Desulfovibrio. Earlier studies have linked this bacterium to the production of hydrogen sulfide—a gas that can damage cells — and to the clumping of the protein α-synuclein. Additional analyses showed that biological pathways related to cell death and the production of inflammatory molecules were more active in the nanoplastic-exposed mice.

Metabolomic profiling of fecal samples identified more than 5,000 metabolites, of which more than 200 showed significant changes in nanoplastic-exposed mice. Many of these altered metabolites were involved in the processing of amino acids, fats, foreign chemicals, and certain drugs. The study also reported significant changes in specific metabolites – including phenylacetylglycine, glycodeoxycholic acid, 7-ketodeoxycholic acid, and 5-hydroxyindole. Histopathologic evaluation of liver tissue demonstrated signs of inflammation in nanoplastic-exposed mice, while levels of cell death in the liver did not differ greatly.

Mass spectrometry of brain tissue detected higher concentrations of A53T α-synuclein when nanoplastics were co-administered. Brain tissue from exposed mice also showed elevated interleukin-6 and lipopolysaccharide levels, and intestinal microbes showed elevated generation of lipopolysaccharide.

Researchers noted that future investigations should include polyethylene, polyamide, charge-neutral particles, and larger microplastic controls to distinguish general nanoplastic effects from those observed with polystyrene. They also indicated that larger, sex-balanced cohorts will be needed to evaluate potential sex-specific responses, as the current sample size limits conclusions in this area.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Kathryn Wighton

Editor, Conexiant

More Articles by Kathryn Wighton

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Turning Tides
Omics
Turning Tides

January 9, 2024

3 min read

A new study shows evidence for sustained human-to-human transmission of mpox since 2016

“Pop” Goes the Sensor
Omics
“Pop” Goes the Sensor

January 19, 2022

1 min read

A new device could help scientists identify signs of arrhythmia, heart attack, and cardiac fibrosis

Improving Risk Stratification
Omics
Improving Risk Stratification

February 3, 2022

1 min read

Two genes have been identified that may be linked to prostate cancer outcomes

The Ultimate Vision for Rare Disease
Omics
The Ultimate Vision for Rare Disease

February 28, 2022

1 min read

Genomics and computational pathology can take rare disease diagnostics to the next level

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.